Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease

ClinicalTrials.gov ID: NCT00930436

Public ClinicalTrials.gov record NCT00930436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Sodium Bicarbonate to Reduce Chronic Kidney Injury in Subjects With Advanced Chronic Kidney Disease (CKD) Who Are Undergoing Angiography

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with Stage 3B, 4,or 5 Chronic Kidney Disease who are to undergo an angiography procedure with contrast agent will be asked if they are willing to join the trial. If so they will be screened and randomized to receive either sodium bicarbonate or saline before, during and after the contrast media is given. They will be asked for serum samples 1 to 3 days, 7, 30, 90 and 180 days after the procedure to evaluate whether the sodium bicarbonate has reduced the incidence of contrast induced chronic kidney disease by measuring their serum creatinine, as well as whether they have required renal dialysis or other renal replacement therapy.

Study identification

NCT ID
NCT00930436
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
MD Scientific
Industry
Enrollment
391 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2010 (Type not available)
Primary completion
Aug 2012 (Actual)
Completion
Sep 2012 (Estimated)
Last update posted
Aug 23, 2012

2010 – 2012

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Osceola Regional Medical Center Kissimmee Florida 34741 —
Northside Hospital St. Petersburg Florida 33709 —
Redmond Regional Medical Center Rome Georgia 30165 —
St. Johns Hospital Springfield Illinois 62701 —
Beth Israel Deaconess Medical Center Boston Massachusetts — —
St Luke's Health System Kansas City Missouri 64111 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Mt Sinai School of Medcine New York New York 10029 —
Stony Brook University Medical Center Stony Brook New York — —
The Christ Hospital Cincinnati Ohio — —
St Luke's Heart and Vascular Center Bethlehem Pennsylvania 18015 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Rhode Island Hospital Providence Rhode Island 02903 —
The Miriam Hospital (Lifespan) Providence Rhode Island 02906 —
Centennial Medical Center Nashville Tennessee 37203 —
Baylor Heart and Vascular Hospital Dallas Texas 75227 —
Fletcher Allen Hospital Burlington Vermont 05401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00930436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2012 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00930436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →